From 1 September the transition period to the TGO 92 ends, meaning from that date, products 'released for supply' by the manufacturer are required to comply with the TGO 92 as the standard for labels od non-prescription medicines.

In response to requests from CMA and other industry, the TGA are providing a streamlined mechanism whereby sponsors who have been experiencing administrative delays and challenges due to the Covid-19 disruptions, are able to request consent via a form to supply listed medicines with labels that continue to comply with the older TGO 69 labelling order until 6 March 2021. Registered medicines will be given until this time and potentially longer depending upon request and circumstances. The cost of this Section 14/14A application is $480 which will accommodate up to 20 products.

Please read this technical alert for more information and details on how to apply.